First Wave BioPharma, Inc.
First Wave BioPharma, Inc. (FWBI) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 31 transactions totaling $41.7K, demonstrating a bearish sentiment with -$41.7K in net insider flow. The most recent transaction on Apr 1, 2024 involved a sale of 75 shares valued at $317.
FWBI Insider Activity Summary
Who Is Buying FWBI Stock?
No significant insider buying has been recorded for FWBI in the recent period.
Who Is Selling FWBI Stock?
No significant insider selling has been recorded for FWBI in the recent period.
Is First Wave BioPharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for FWBI is bearish with an Insider Alignment Score of 0/100 and a net flow of -$41.7K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
FWBI Frequently Asked Questions
Understanding FWBI Insider Activity
Insider trading at First Wave BioPharma, Inc. (FWBI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading FWBI stock, having executed 31 transactions in the past 90 days. The most active insider is James Sapirstein (Executive), who has made 9 transactions totaling $25.1K.
Related Tools
Track First Wave BioPharma, Inc. Insider Activity
Get notified when executives and directors at FWBI file new Form 4 transactions